Especially the close interaction between Board of Directors and the Leadership is crucial in the vulnerable early days of transformation from promising research to sustainable business. I have been intimately engaged in the organizational build of several companies, including both the strategic focusing of new innovation and interaction with existing and potential investors. Recently, I have held the position of CTO at Adcendo while the company successfully secured several series A financing rounds. In addition to a substantial technical understanding, I recognize leveraging on the strengths of a team and the importance of building a resilient organization that can navigate an ever-changing landscape in the life science world.